People who are infected with hepatitis C virus and have kidney failure need a kidney transplant.
Why did the researchers do this particular study? Recent studies have found that it is possible to transplant kidneys from donors who are infected with hepatitis C virus into patients who need a transplant and are already infected with the virus. In addition, drugs are available to cure most patients of hepatitis C virus, including those who have kidney failure. Infected patients who need a kidney transplant have 2 options. One option is to receive an infected kidney and then use drugs after the transplant to cure themselves and the transplanted kidney of the virus. Another option is to use the drugs first to get rid of the virus and then to receive a kidney from a donor who does not have hepatitis C virus infection.
Who was studied?
Because it may not be possible to do this type of research with actual people, the investigators created a model that allowed them to estimate possible outcomes without using actual people.
How was the study done?
The model was a computer program that combined the best available information to approximate what might happen to participants in a real-world clinical trial.
What did the researchers find?
Infected people who received a kidney from an infected donor and then used drugs were more likely to live longer and have lower costs than infected people who used drugs first and then received a kidney that was not infected.
What were the limitations of the study?
These results are best estimates, but they are estimates and not real data.
What are the implications of the study?
People who are infected with hepatitis C virus, have kidney failure, and need a kidney transplant are more likely to be better off if they get their kidney from an infected donor and then take drugs to cure themselves and their transplanted kidney of the infection. 
